Stock Track | Oruka Therapeutics Soars 5.42% in Pre-market on Analyst Target Price Hikes

Stock Track

04/28

Oruka Therapeutics Inc's stock surged 5.42% during pre-market trading on Tuesday, following positive analyst actions that boosted investor sentiment.

The significant price movement comes after Barclays raised its target price for Oruka Therapeutics to $160 from $78, representing a substantial increase in valuation expectations. Additionally, UBS also increased its target price for the company to $100 from $75, further supporting the positive outlook for the healthcare stock.

Analysts have shown increased interest in Oruka Therapeutics, with mixed opinions emerging on healthcare sector stocks including both Zoetis and Oruka Therapeutics. The dual target price upgrades from major financial institutions appear to have driven the pre-market surge as investors react to the improved valuation assessments.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/news/1122386649"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1122386649\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1122386649?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-28 21:12","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1122386649","market":"nz","top_or_hot":-1,"title":"Stock Track | Oruka Therapeutics Soars 5.42% in Pre-market on Analyst Target Price Hikes","media":"Stock Track","content":"<p>Oruka Therapeutics Inc's stock surged 5.42% during pre-market trading on Tuesday, following positive analyst actions that boosted investor sentiment.</p><p>The significant price movement comes after Barclays raised its target price for Oruka Therapeutics to $160 from $78, representing a substantial increase in valuation expectations. Additionally, UBS also increased its target price for the company to $100 from $75, further supporting the positive outlook for the healthcare stock.</p><p>Analysts have shown increased interest in Oruka Therapeutics, with mixed opinions emerging on healthcare sector stocks including both Zoetis and Oruka Therapeutics. The dual target price upgrades from major financial institutions appear to have driven the pre-market surge as investors react to the improved valuation assessments.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Oruka Therapeutics Soars 5.42% in Pre-market on Analyst Target Price Hikes</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Oruka Therapeutics Soars 5.42% in Pre-market on Analyst Target Price Hikes\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-04-28 21:12</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Oruka Therapeutics Inc's stock surged 5.42% during pre-market trading on Tuesday, following positive analyst actions that boosted investor sentiment.</p><p>The significant price movement comes after Barclays raised its target price for Oruka Therapeutics to $160 from $78, representing a substantial increase in valuation expectations. Additionally, UBS also increased its target price for the company to $100 from $75, further supporting the positive outlook for the healthcare stock.</p><p>Analysts have shown increased interest in Oruka Therapeutics, with mixed opinions emerging on healthcare sector stocks including both Zoetis and Oruka Therapeutics. The dual target price upgrades from major financial institutions appear to have driven the pre-market surge as investors react to the improved valuation assessments.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ORKA","symbol_name":"ORUKA THERAPEUTICS INC","start_time":0,"source_url":"","article_id":"1122386649","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1122386649","pubTimestamp":1777381961,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Oruka Therapeutics Inc's stock surged 5.42% during pre-market trading on Tuesday, following positive analyst actions that boosted investor sentiment.The significant price movement comes after...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ORKA":"ORUKA THERAPEUTICS INC"},"translate_title":"个股追踪|分析师上调目标价Oruka Therapeutics盘前大涨5.42%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ORKA":1},"content_text":"Oruka Therapeutics Inc's stock surged 5.42% during pre-market trading on Tuesday, following positive analyst actions that boosted investor sentiment.The significant price movement comes after Barclays raised its target price for Oruka Therapeutics to $160 from $78, representing a substantial increase in valuation expectations. Additionally, UBS also increased its target price for the company to $100 from $75, further supporting the positive outlook for the healthcare stock.Analysts have shown increased interest in Oruka Therapeutics, with mixed opinions emerging on healthcare sector stocks including both Zoetis and Oruka Therapeutics. The dual target price upgrades from major financial institutions appear to have driven the pre-market surge as investors react to the improved valuation assessments.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}